Resultados de procura - Andrea B. Apolo

Limitar resultados
  1. 1
    Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer

    Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer por Andrea B. Apolo, Neeta Pandit‐Taskar, Michael J. Morris

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Targeted therapies in urothelial carcinoma

    Targeted therapies in urothelial carcinoma por Monalisa Ghosh, Sam J. Brancato, Piyush K. Agarwal, Andrea B. Apolo

    Publicado 2014
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Immunotherapy: a new treatment paradigm in bladder cancer

    Immunotherapy: a new treatment paradigm in bladder cancer por Nicole N. Davarpanah, Akira Yuno, Jane B. Trepel, Andrea B. Apolo

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Trimodality Therapy in Bladder Cancer

    Trimodality Therapy in Bladder Cancer por Christopher Premo, Andrea B. Apolo, Piyush K. Agarwal, Deborah E. Citrin

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Multimodal management of muscle-invasive bladder cancer

    Multimodal management of muscle-invasive bladder cancer por Jong‐Chul Park, Deborah E. Citrin, Piyush K. Agarwal, Andrea B. Apolo

    Publicado 2014
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing Loss

    Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing Loss por Bharath Ramaswamy, Soumen Roy, Andrea B. Apolo, Benjamin Shapiro, Didier A. Depireux

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A review

    Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A review por Bradley A. McGregor, Amir Mortazavi, Lisa M. Cordes, Cristina Salabao, Susan Vandlik, Andrea B. Apolo

    Publicado 2021
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer

    Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer por Andrea B. Apolo, Jamie C. Riches, Heiko Schöder, Oğuz Akın, A. Trout, Matthew I. Milowsky, Dean F. Bajorin

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival

    Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival por Juliane Manitz, Sandra P. D’Angelo, Andrea B. Apolo, S. Peter Eggleton, Marcis Bajars, Oliver Bohnsack, James L. Gulley

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Cabozantinib for the treatment of solid tumors: a systematic review

    Cabozantinib for the treatment of solid tumors: a systematic review por Pablo Maroto, Camillo Porta, Jaume Capdevila, Andrea B. Apolo, Santiago Viteri, Cristina Rodríguez‐Antona, Lidia Martín, Daniel Castellano

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  11. 11
    Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report

    Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report por Cecilia Monge, Hoyoung Maeng, Alessandra Brofferio, Andrea B. Apolo, Bharath Sathya, Andrew E. Arai, James L. Gulley, Marijo Bilušić

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib

    Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib por Rena C. Zuo, Andrea B. Apolo, John J. DiGiovanna, Howard L. Parnes, Corrine Keen, Swati Nanda, William L. Dahut, Edward W. Cowen

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy

    Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy por Andrea B. Apolo, Irina Ostrovnaya, Susan Halabi, Alexia Iasonos, George Philips, Jonathan E. Rosenberg, Jamie C. Riches, Eric J. Small, Matthew I. Milowsky, Dean F. Bajorin

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer

    Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer por Vid Leko, Lucas A. McDuffie, Zhili Zheng, Jared J. Gartner, Todd D. Prickett, Andrea B. Apolo, Piyush K. Agarwal, Steven A. Rosenberg, Yong‐Chen Lu

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions

    Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions por Nick G. Cowan, Yiyi Chen, Tracy M. Downs, Bernard H. Bochner, Andrea B. Apolo, Michael P. Porter, Jeffrey C. La Rochelle, Christopher L. Amling, Theresa M. Koppie

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90- Targeted Therapy

    Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90- Targeted Therapy por Soraya Alarcon, Mehdi Mollapour, M.-J. Lee, Shinji Tsutsumi, S. Lee, Y.S. Kim, Thomas L. Prince, Andrea B. Apolo, Giuseppe Giaccone, Wanping Xu, Len Neckers, Jane B. Trepel

    Publicado 2012
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  17. 17
    Phase II Study of Gemcitabine, Carboplatin, and Bevacizumab in Patients With Advanced Unresectable or Metastatic Urothelial Cancer

    Phase II Study of Gemcitabine, Carboplatin, and Bevacizumab in Patients With Advanced Unresectable or Metastatic Urothelial Cancer por Arjun Vasant Balar, Andrea B. Apolo, Irina Ostrovnaya, Svetlana Mironov, Alexia Iasonos, A. Trout, Ashley Marie Regazzi, Ilana Garcia-Grossman, David Gallagher, Matthew I. Milowsky, Dean F. Bajorin

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Advances in medical imaging for the diagnosis and management of common genitourinary cancers

    Advances in medical imaging for the diagnosis and management of common genitourinary cancers por Mohammadhadi Bagheri, Mark A. Ahlman, Liza Lindenberg, Barış Türkbey, Jeffrey Lin, A. Cahid Civelek, Ashkan A. Malayeri, Piyush K. Agarwal, Peter L. Choyke, Les Folio, Andrea B. Apolo

    Publicado 2017
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  19. 19
    Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial

    Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, rando... por David Cella, Robert J. Motzer, Cristina Suárez, Steven I. Blum, Flavia Ejzykowicz, Melissa Hamilton, Joel Wallace, Burçin Şimşek, Joshua Zhang, Cristina Ivanescu, Andrea B. Apolo, Toni K. Choueiri

    Publicado 2022
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies

    Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies por Carl Noble, Sapna Gangaputra, Ian Thompson, Amy Yuan, Andrea B. Apolo, Jung‐Min Lee, George N. Papaliodis, Shilpa Kodati, Rachel Bishop, M. Teresa Magone, Lucia Sobrin, H. Nida Sen

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: